Boehringer Awarded Summary Judgment in Ga. Federal Pradaxa Wrongful Death Action

ATLANTA — A Georgia federal judge has awarded Boehringer Ingelheim Pharmaceuticals Inc. summary judgment in a Pradaxa action, finding the drug maker provided the Food and Drug Administration with updated information regarding the blood thinner’s risks, but the agency took no action to update the label.

In a Sept. 29 order, Judge William Ray II of the U.S. District Court for the Northern District of Georgia concluded that the plaintiff’s claims, all of which sound in failure to warn, are preempted by federal law because “plaintiff presented no data or analyses regarding the use of Pradaxa that demonstrates a different …